| Tag | Content |
|---|
EnhancerAtlas ID | HS023-24525 |
Organism | Homo sapiens |
Tissue/cell | CD8+ |
Coordinate | chr8:101919430-101921710 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ESR1 | MA0112.3 | chr8:101920239-101920256 | CAGGTCATCCTGACATC | - | 6.61 | | NFYB | MA0502.1 | chr8:101920315-101920330 | CTGATTGGTCCATGG | - | 6.98 | | SP2 | MA0516.2 | chr8:101920878-101920895 | AAGCGGGCGGGGCTTCG | - | 6.55 | | SPIC | MA0687.1 | chr8:101921475-101921489 | AAAATGAGGAAGCA | + | 6.04 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_10716 | chr8:101917592-101921965 | CD19_Primary | | SE_11102 | chr8:101916604-101922454 | CD20 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 3 | Chromosome | Start | End |
| chr8 | 101921400 | 101921561 | | chr8 | 101920209 | 101920392 | | chr8 | 101919498 | 101919916 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH08I100905 | chr8 | 101917929 | 101922028 |
|
Enhancer Sequence | TATGTCCCCT GGAAGGCTGT CAGGAGACAG TTTTGTCACA GGATTCTTGG GGTGTCACTT 60
TTTCAGCTGG AAACCTCTGT GGCCAGTGGC GTCTTTGCCT GAGTTTTGTT TGGGCCCCCT 120
GGGCTTGTTC TGCCCACTCA GCCCAGCAGG CTGTGCTTGG CTCACACTAC CGGCCCGGAT 180
CCCACACCTG CCAGGGGCAA GCCAGGTGCT GAGCAGCAAG GGATGTGTGA GCAAGCACAG 240
GGTCTGGCCA CTGTGCACAG CCAGGTGTAT GGGCTGCCAG GTGTATGGGC TGTGCTGGAG 300
AGGACAGTTC CAGGTGCTGG CCCAGGCACC TGCTGCATGT GAGGCTGCAG CTGGATCAGG 360
CGTATCATAT CGCAAGCGCT TCTACTGCAG GCACTGGGCA ACGTGGTGGC ACCGAGAAGC 420
TTGGAGACAA CAGGAACTGC AGAGCCCCAA AGAGGGTGTC ACAGACCTGG CTCGGGGAGC 480
TCCTAGGTCT GGGCTCCCTA AAGGGTAGCA GTTCTCTCCT AGTCACCTGC AACATGGTGA 540
GTGGGGTGGG GGGCGTGTTT CAGCCCTGTT TGTGTTACAG CTCTTTCAGT CCCGCCATTC 600
AGCGGGTCCG AGTTCTTGTC GCAAGTCCAG GAAGAATGAG GTATATGGAA AACTGGAGGG 660
TGAGCAAGGC AGAGAGGAGC TTCATTGAGT GACAGAACAG CTCTCAGGAG ACCTGAAGTG 720
GGTAGTTCCT TTCTGCAGGC ACGTGGTCCT GAGGAGTGTC CAGCTCTCAG GGGAGAGGAG 780
ACCCGGAGTG AGAAGCTCTT ATCCGCAGGC AGGTCATCCT GACATCTCTC TGCGAGTCTA 840
GCTGAGTCTG GGACTTCTAC GGGTTTTGAA GGGAGGAAGT GTGTGCTGAT TGGTCCATGG 900
GTGGCCATCG GCGGGGCTGG AAAAAACACC AAAAGTTCTC ACTCCCGCGG TGGACTCCAC 960
TGGGAACCGA CAGGCCCCAG GCCTCAGGTC GTCCCTGTCT TCAAAGTGGG GCTTCACCGG 1020
GACCGCCCCT TTCCACCCGG GAACCTATCT GCCTCCTGCT GCCATTGACA GGTTTGTCCA 1080
CCGCAATGCC CTGGCTATCC GTGCCATGGG GGACCTGCAG GCCCCTTTCA GCCTTCCTCC 1140
CCGTGCTCGT TGGCACCCAA AGTCTGGAGG GGGCAGAGGC GGCAGGGGGC TGGCATGGCA 1200
GGGCTGCCCC GAGTGTACGC ACACCCGGCC GGGTTGCAAA GCGCCCGGAC TTGACCAAAA 1260
CTTTGCTCAG TCCCGGAGCA GACACTGGGA GTCTGGAGAA GCCACGCATC TGGAGCAGGC 1320
ACTTCTGAGC CTGCAGAGGA AAGGGGACTT CCCGGGGCCC CCGAGAGCAC AGGGATGCCC 1380
GGTTTGGGAG CCTTGGCTAG GCAGCTGCAG CTGCGCAGGA GGGTGGGGCT TCCGCCCCGC 1440
CGACTCAGAA GCGGGCGGGG CTTCGGCCTC TTCCCGGCTC CCGCCAGCTC CGTGGAGCCT 1500
GGAGCCCCAG CCGCGCCTCC CTGGCTGCAG CTGCTGTATT CACAGCAGCC GCTTCAGGCG 1560
GGCCGCCACG GCGATCAGTT TTTCATGGCC TCCAGGTTCT GATGAAGCGT GGGATTTTCT 1620
GCCCTGTACC CCTCAGAACA AGAAACCACC TTACTGCAGT CTGTAAGTGG CTCCTCAGTA 1680
ACAGGGCACC CACAACTTTC ATGGCATCCG CCCGTTACTT TTGTGTCTTC CCTTCTGTGT 1740
GTGGGACCAG GAACCTGTGG AGCTGGCTCT CAGCTTACTG CTCTTTCTGC TATGTAAGCG 1800
ATCAACTGTC TGACTCTAAA AGTGACTCGT ATTTTTCCTT TTGAATCAGA CAGACCCTGA 1860
TCTGGGTTTT GCTTTGTGTT TTATGTGTGA GCTTTATACT CTGAAGTCGC TTTATATTTT 1920
ATTTTTTCAT TTATTAACAA ATATTTCTAT CATATTTCCT ATGGACCAAG CACTTTACAA 1980
AGTATTAATA CATTTAATAC TTGGTATAAC CCTATAAAGT CAGTGCTATT ATCACCCTCA 2040
CTTTAAAAAT GAGGAAGCAA AGCCCTAGAG TGGTTAAGAA ACTTGTCCAA GATTACACAG 2100
CCAGTGGCAG AGTCAGATGG GCTGCTCTGG AGTCAAGGCT CTTAACCACT GTGTTTTGCT 2160
GCCTTATGTT AACAGAGTTT ACACTTAGGG CACTTTTTCT CAGACAACAC ACATCAGAAG 2220
CACCTAGATT ACCCAGTTGA AATGCAGTTT CCTGGGTTCC ATCCGGACCT ATCCTGTGAG 2280
|
